Systematic Financial Management LP Sells 55,006 Shares of InMode Ltd. $INMD

Systematic Financial Management LP decreased its position in shares of InMode Ltd. (NASDAQ:INMDFree Report) by 4.8% in the 4th quarter, HoldingsChannel reports. The fund owned 1,082,416 shares of the healthcare company’s stock after selling 55,006 shares during the period. Systematic Financial Management LP’s holdings in InMode were worth $15,901,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the stock. Leonteq Securities AG bought a new stake in InMode during the fourth quarter worth $26,000. Plan A Wealth LLC grew its holdings in InMode by 16.2% during the fourth quarter. Plan A Wealth LLC now owns 12,878 shares of the healthcare company’s stock worth $189,000 after buying an additional 1,793 shares in the last quarter. Advisory Services Network LLC bought a new stake in InMode during the third quarter worth $37,000. CWA Asset Management Group LLC grew its holdings in InMode by 2.7% during the fourth quarter. CWA Asset Management Group LLC now owns 94,541 shares of the healthcare company’s stock worth $1,389,000 after buying an additional 2,471 shares in the last quarter. Finally, Ashton Thomas Private Wealth LLC grew its holdings in InMode by 13.3% during the third quarter. Ashton Thomas Private Wealth LLC now owns 26,459 shares of the healthcare company’s stock worth $394,000 after buying an additional 3,113 shares in the last quarter. Institutional investors own 68.04% of the company’s stock.

Analyst Ratings Changes

INMD has been the subject of a number of recent analyst reports. BTIG Research restated a “neutral” rating on shares of InMode in a research note on Monday, January 26th. Barclays set a $19.00 price objective on InMode and gave the company an “overweight” rating in a research note on Thursday, May 7th. Finally, Robert W. Baird reduced their price objective on InMode from $17.00 to $14.00 and set a “neutral” rating for the company in a research note on Thursday, May 7th. One analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, InMode currently has an average rating of “Hold” and a consensus price target of $16.00.

Check Out Our Latest Stock Report on InMode

InMode Price Performance

Shares of NASDAQ INMD opened at $13.74 on Monday. The firm has a market capitalization of $870.55 million, a P/E ratio of 10.10 and a beta of 1.97. The stock’s 50-day simple moving average is $13.90 and its two-hundred day simple moving average is $14.23. InMode Ltd. has a twelve month low of $12.72 and a twelve month high of $16.74.

InMode (NASDAQ:INMDGet Free Report) last announced its earnings results on Wednesday, May 6th. The healthcare company reported $0.25 earnings per share for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.05). The business had revenue of $82.02 million during the quarter, compared to the consensus estimate of $79.84 million. InMode had a return on equity of 13.47% and a net margin of 23.27%.InMode’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.31 earnings per share.

InMode Profile

(Free Report)

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.

Read More

Want to see what other hedge funds are holding INMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InMode Ltd. (NASDAQ:INMDFree Report).

Institutional Ownership by Quarter for InMode (NASDAQ:INMD)

Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.